- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/20 - Antivirals for DNA viruses
Patent holdings for IPC class A61P 31/20
Total number of patents in this class: 2948
10-year publication summary
|
83
|
100
|
181
|
241
|
307
|
328
|
335
|
300
|
239
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
105 |
| Hoffmann-La Roche Inc. | 3267 |
101 |
| Janssen Sciences Ireland Unlimited Company | 435 |
92 |
| Aligos Therapeutics, Inc. | 145 |
61 |
| Gilead Sciences, Inc. | 1951 |
56 |
| F. Hoffmann-La Roche AG | 7942 |
55 |
| Arbutus Biopharma Corporation | 189 |
31 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 670 |
29 |
| Sunshine Lake Pharma Co., Ltd. | 570 |
29 |
| Xiamen University | 515 |
24 |
| Assembly Biosciences, Inc. | 68 |
21 |
| VIR Biotechnology, Inc. | 132 |
19 |
| Emory University | 1588 |
18 |
| Glaxosmithkline Biologicals S.A. | 1696 |
17 |
| Enanta Pharmaceuticals, Inc. | 422 |
17 |
| Intervet International B.V. | 1283 |
17 |
| Boehringer Ingelheim Animal Health USA Inc. | 495 |
17 |
| Novartis AG | 11254 |
15 |
| Intervet Inc. | 872 |
14 |
| Boehringer Ingelheim Vetmedica GmbH | 1289 |
12 |
| Other owners | 2198 |